How to Choose a Fertility Hospital in Thailand: An Evaluation Framework Based on Success Rates, Laboratory Standards, and Patient Feedback

Opening: Real Consultation Scenario

How to Choose a Fertility Hospital in Thailand: The Direct Answer

There is no single "best" ranking for fertility hospitals in Thailand; the choice must be matched to individual circumstances. The core evaluation framework includes five dimensions:

• Embryology Laboratory Standards — Whether it holds CC-level or higher certification, incubator type (time-lapse imaging incubator vs. traditional incubator), and culture medium quality control system.
• Stratified Clinical Pregnancy Rate Data — Live birth rates calculated separately by age, infertility cause, and transfer cycle type (fresh/frozen embryo), rather than a single overall success rate.
• Embryologist Team Stability — Embryologist seniority, staff turnover rate, blastocyst formation rate, and freeze-thaw survival rate as process indicators.
• PGT Technical Level — Biopsy timing (Day 5 vs. Day 6), testing platform (NGS or aCGH), and collaboration model with the genetics laboratory.
• Multilingual Services and Medical Coordination Capability — Whether there is a dedicated Chinese coordinator, whether remote video consultations are offered, and whether assistance with visas and travel arrangements is provided.

Why "Which Fertility Hospital in Thailand is Best" Has Become a Difficult Question

Information asymmetry is the root cause. Domestic patients mainly obtain information about Thai fertility hospitals through three channels: intermediary agencies, online forums, and social media. Each of these channels has significant limitations:

• Intermediary Agencies — They typically only recommend hospitals with which they have cooperative relationships and may omit information unfavorable to their partners.
• Online Forums — Patient sharing is mostly personal experience with small sample sizes and lacks medical professionalism, making it easy to overgeneralize individual experiences.
• Social Media — Information is often fragmented, lacks systemization, and carries the risk of being infiltrated by commercial promotion.

Furthermore, data disclosure standards among Thai fertility hospitals themselves are inconsistent. Some hospitals include biochemical pregnancies in their reported "clinical pregnancy rate," while others use "live birth rate"; some stratify by age group, while others provide only a single vague figure. These differences make horizontal comparisons very difficult.

Real Dimensions Reproductive Doctors Use to Evaluate Thai Hospitals

An experienced reproductive doctor, when choosing a partner or referral hospital, focuses on the following technical details:

• Laboratory Quality Control System — Incubator type (especially whether tri-gas incubators are used), culture medium brand and batch management, standardization of embryo grading systems, and freeze-thaw cycle survival rate (should be > 95%).
• Degree of Individualization in Clinical Ovarian Stimulation Strategies — Whether mild stimulation or natural cycle protocols are used for poor ovarian responders (e.g., AMH < 0.8), and whether antagonist protocols are used for polycystic ovary syndrome to reduce OHSS risk.
• Core Competency of Embryologists — Blastocyst formation rate (the proportion of normally fertilized oocytes that develop into usable blastocysts by Day 5-6 should be > 50%), and embryo survival rate after PGT biopsy.
• Reliability of Genetic Testing — Whether the testing platform is NGS or aCGH, whether internal quality control data is available, and whether interpretation criteria for chromosomal mosaicism are provided.

The doctor's logic is: first, check if the laboratory can produce good blastocysts; second, see if the clinician can adjust the protocol based on the patient's condition; and finally, assess whether the entire team has a robust quality review mechanism.

Core Differences Among Major Fertility Centers in Thailand

There are approximately 20 assisted reproduction institutions licensed by the Thai Ministry of Public Health (MOPH). Among those serving international patients, significant differences exist in the following areas:

5 Key Details Most Easily Overlooked

When screening hospitals, patients often focus solely on success rate numbers while ignoring the following factors that directly impact outcomes:

• Embryologist Seniority and Stability — Embryo culture is a manual skill; teams with high turnover struggle to maintain consistent quality. Inquire about the average years of experience and staff turnover rate at the center.
• Oocyte Freeze-Thaw Survival Rate — If involving frozen eggs or egg donation, the survival rate is a direct process indicator of laboratory quality and should be > 90%.
• Ratio of Blastocysts Cultured to Day 5 vs. Day 6 — Blastocysts formed on Day 6 have a higher chromosomal abnormality rate than those formed on Day 5. If a center transfers a high number of Day 6 blastocysts without distinguishing them in reports, caution is warranted.
• PGT Mosaicism Interpretation Criteria — Different laboratories have varying reporting and management strategies for mosaicism (20%-80% abnormal cells), which directly affects the assessment of embryo usability.
• Individualization of Endometrial Preparation Protocol Before Transfer — Whether ERA testing is routinely performed (especially for recurrent implantation failure patients), and whether medication protocols are adjusted based on endometrial thickness.

4 Traps Most Likely to Fall Into

Based on past patient feedback, the following four misconceptions are most common:

• Misled by "Rankings" — There is no official ranking of fertility hospitals in Thailand. All "Top 5 Thailand IVF Hospital Rankings" are compiled by commercial entities or self-media, with non-transparent sorting criteria.
• Misled by "Success Rates" — Some hospitals include biochemical pregnancies (positive HCG but not ongoing) in their reported "success rate," rather than live birth rates. The correct approach is to request the "live birth rate per transfer cycle" stratified by age group.
• Misled by "Guaranteed Success" — There is no 100% success in assisted reproduction. Any claim of "guaranteed success" or "full refund if not successful" either involves strict screening criteria (accepting only patients with the best prognosis) or is medically unethical.
• Misled by "Low-Cost Packages" — Low-cost packages may use cheaper culture media and consumables, or exclude key costs like PGT and embryo freezing, resulting in a higher total expenditure.

From Consultation to Transfer: Standard Process and Timeline

A complete IVF cycle in Thailand typically proceeds through the following steps. Understanding the process in advance helps with reasonable planning of time and budget:

Overall, a cycle including PGT from the initial consultation to the pregnancy test takes approximately 2-3 months. Without PGT, the time can be reduced to 1.5-2 months.

Frequently Asked Questions: Practitioner Answers

Is the IVF success rate in Thailand really higher than in my home country?

It cannot be generalized. For patients <35 years old with normal ovarian reserve, top domestic reproductive centers have live birth rates comparable to excellent centers in Thailand. Some Thai centers may have advantages in areas such as higher prevalence of PGT technology, more flexible embryo culture strategies, and greater experience with individualized protocols for older patients. However, hospital selection should be based on specific data, not geographic labels.

How much does IVF in Thailand typically cost?

A routine cycle (including medical fees, translation, accommodation, and meals) ranges from approximately 80,000 to 150,000 RMB. Medical fees account for about 60%-70% of this, varying by hospital, medication protocol, and whether PGT is performed. It is advisable to obtain a detailed cost breakdown during the remote consultation, confirming whether it includes embryo freezing fees, PGT testing fees, transfer fees, etc.

Can I choose the sex of the baby with IVF in Thailand?

Thai law permits PGT for sex selection based on medical indications, such as sex-linked genetic disorders. For non-medical sex selection, policies vary among hospitals, and regulations may change. It is recommended to confirm the latest policy directly with the hospital during consultation and sign an informed consent form.

Is IVF in Thailand suitable for older women (≥40 years old)?

A basic fertility assessment should be completed first. If AMH > 0.8 ng/mL, antral follicle count > 3, and there are no other severe comorbidities, some Thai centers have experience with ovulation stimulation and embryo culture strategies for older patients. If AMH < 0.5 ng/mL, the probability of egg retrieval should be carefully evaluated, and one should be mentally prepared for the possibility of needing multiple cycles.

How far in advance should I prepare for IVF in Thailand?

It is recommended to start preparations 2-3 months in advance. Items that should be completed earlier include: basic fertility assessment (AMH, FSH, antral follicle count), semen analysis, chromosome testing, infectious disease screening, and passport application. For those of advanced age or with diminished ovarian reserve, it is advisable to complete tests and begin optimization 3-6 months in advance. Some test results (e.g., infectious disease screening, chromosome karyotype) are valid for longer periods, but semen analysis and endocrine tests should be completed within 1-3 months before starting the cycle.

10-year Consultant Knowledge Base ID: ART-TH-006 Content Version: 2025.06